PT  - JOURNAL ARTICLE
AU  - Olson, Daniel J
AU  - Larkin, James
AU  - Hong, Young
AU  - Thomas, Sajeve
AU  - Martin-Liberal, Juan
AU  - Furness, Andrew JS
AU  - Terheyden, Patrick
AU  - In, Gino K
AU  - Poklepovic, Andrew S
AU  - Samhouri, Yazan
AU  - Lammers, Philip
AU  - Atkinson, Victoria
AU  - Nguyen, Ryan H
AU  - Peretz, Idit
AU  - Butler, Marcus
AU  - Finckenstein, Friedrich Graf
AU  - Chou, Jeffrey
AU  - Wu, Xiao
AU  - Sulur, Giri
AU  - Shi, Wen
AU  - Haanen, John B
TI  - 778 TILVANCE-301, a phase 3 study of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy combined with pembrolizumab (pembro) vs pembro alone in treatment-naïve unresectable or metastatic melanoma
AID  - 10.1136/jitc-2023-SITC2023.0778
DP  - 2023 Nov 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - A875--A875
VI  - 11
IP  - Suppl 1
4099  - http://jitc.bmj.com/content/11/Suppl_1/A875.short
4100  - http://jitc.bmj.com/content/11/Suppl_1/A875.full
SO  - J Immunother Cancer2023 Nov 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.